ArticleFrontiers in oncology2022

Modelling of immune response in chronic myeloid leukemia patients suggests potential for treatment reduction prior to cessation.

Elena Karg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.